دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Machine Learning Predictive Outcomes Modeling in Inflammatory Bowel Diseases
Aamir Javaid, BS, Omer Shahab, MD, William Adorno, MS, Philip Fernandes, MD, Eve May, MD, Sana Syed, MD, MSCR, MSDS
doi : 10.1093/ibd/izab187
Inflammatory Bowel Diseases, Volume 28, Issue 6, June 2022, Pages 819–829
Protein Kinase CK2 Maintains Reciprocal Balance Between Th17 and Treg Cells in the Pathogenesis of UC
Guanjun Dong, PhD, Yonghong Yang, MS, Hairong Zhang, MS, Wei Yu, MS, Heng He, MS, Fengxian Dai, BS, Cuimei Ma, BS, Yibo Wang, MS, Fengqin Zhu, MD, PhD, Huabao Xiong, PhD, Guangxi Zhou, MD, PhD
doi : 10.1093/ibd/izab312
Peripartum Exposure to Biologic Therapy Does Not Impact Postpartum Wound Healing in Women With IBD
Aiya Aboubakr, MD, Zoë S Gottlieb, MD, Alexa Rae Riggs, MPH, Shaelyn O’Hara Johnson, MD, Darwin Jimenez, BS, Patricia Rekawek, MD, Maria Teresa Mella, MD, Marla C Dubinsky, MD
doi : 10.1093/ibd/izab165
Revisiting the Association Between Inflammatory Bowel Disease and Parkinson’s Disease
Matthew D Coates, MD, PhD, Djibril M Ba, MPH, PhD, Guodong Liu, PhD, Shannon Dalessio, MA, Douglas L Leslie, PhD, Xuemei Huang, MD, PhD
doi : 10.1093/ibd/izab175
Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia
Jordan E Axelrad, MD, MPH, Adam Faye, MD, MS, James C Slaughter, PhD, Noam Harpaz, MD, Steven H Itzkowitz, MD, Shailja C Shah, MD, MPH
doi : 10.1093/ibd/izab177
What Is a Flare? The Manitoba Living With IBD Study
Kelcie Witges, MS, Kathryn Sexton, PhD, Lesley A Graff, PhD, Laura E Targownik, MD, Lisa M Lix, PhD, Clove Haviva, PhD, James Stone, MD, Leigh Anne Shafer, PhD, Kathy Vagianos, MS, Charles N Bernstein, MD
doi : 10.1093/ibd/izab192
Health Care Costs and Resource Utilization Among Patients With Crohn’s Disease With and Without Perianal Fistula
Grace Chen, PhD, Vasantha Pedarla, MS, Kyle D Null, PharmD, PhD, Susan E Cazzetta, PharmD, Qasim Rana Khan, MBBS, David A Schwartz, MD
doi : 10.1093/ibd/izab198
The Impact of NAFLD on Hospitalization Outcomes in Patients With Inflammatory Bowel Diseases: Nationwide Analysis
Shaya Noorian, MD, Yejoo Jeon, MD, Minh T Nguyen, MPH, Jenny Sauk, MD, Berkeley N Limketkai, MD, PhD
doi : 10.1093/ibd/izab199
High Levels of Psychological Resilience Are Associated With Decreased Anxiety in Inflammatory Bowel Disease
Alicia Philippou, MD, Priya Sehgal, MD, MPH, Ryan C Ungaro, MD, MS, Kelly Wang, MPH, Emilia Bagiella, PhD, Marla C Dubinsky, MD, Laurie Keefer, PhD
doi : 10.1093/ibd/izab200
Efficacy of Ustekinumab in Crohn’s Disease With and Without Concurrent Autoimmune Skin Disease
Elena Fradkov, MD, Jessica Sheehan, MD, Kelly Cushing, MD, MSc, Peter D R Higgins, MD, PhD, MSc
doi : 10.1093/ibd/izab201
Composition and Stability of the Vaginal Microbiota of Pregnant Women With Inflammatory Bowel Disease
Janet E Hill, PhD, Juan-Nicolás Peña-Sánchez, MD, PhD, Champika Fernando, MSc, Aline C Freitas, PhD, Niradha Withana Gamage, MSc, Sharyle Fowler, MD
doi : 10.1093/ibd/izab314
Deleterious Genetic Variation Across the NOD Signaling Pathway Is Associated With Reduced NFKB Signaling Transcription and Upregulation of Alternative Inflammatory Transcripts in Pediatric Inflammatory Bowel Disease
James J Ashton, PhD, Konstantinos Boukas, PhD, Imogen S Stafford, MSci, Guo Cheng, PhD, Rachel Haggarty, RN, Tracy A F Coelho, PhD, Akshay Batra, MD, Nadeem A Afzal, MD, Anthony P Williams, PhD, Marta E Polak, PhD, R Mark Beattie, FRCPCH, Sarah Ennis, PhD
doi : 10.1093/ibd/izab318
Caveolin-1 Alleviates Crohn’s Disease–induced Intestinal Fibrosis by Inhibiting Fibroblasts Autophagy Through Modulating Sequestosome 1
Mengli Yu, MBBS, PhD candidate, Wei Zhu, MS, Jinhai Wang, MS, Xueyang Chen, PhD, Xinjue He, MD, Bingru Lin, MBBS, Li Cen, MS, Tianyu Zhou, MBBS, Chao Lu, MS, Chaohui Yu, PhD, Jing Sun, MD
doi : 10.1093/ibd/izab342
Eating Disorders: Diagnosis and Management Considerations for the IBD Practice
Graziella Rangel Paniz, MD, Jocelyn Lebow, LP, PhD, Leslie Sim, LP, PhD, Brian E Lacy, MD, PhD, Francis A Farraye, MD, MSc, Monia E Werlang, MD
doi : 10.1093/ibd/izab138
Bringing to Light the Risk of Colorectal Cancer in Inflammatory Bowel Disease: Mucosal Glycosylation as a Key Player
Eduarda Leite-Gomes, MSc, Ana M Dias, PhD, Catarina M Azevedo, MSc, Beatriz Santos-Pereira, MSc, Mariana Magalhães, MD, Mónica Garrido, MD, Rita Amorim, MD, Paula Lago, MD, Ricardo Marcos-Pinto, MD, PhD, Salomé S Pinho, DVM, PhD
doi : 10.1093/ibd/izab291
Did You Get My Message? Trends and Predictors of Inflammatory Bowel Disease Patient-to-Provider Electronic Messaging
Megan K Lutz, MD, Lindsay A Matthews, MD, Wen-Jan Tuan, DHA, Freddy Caldera, MD, Sumona Saha, MD
doi : 10.1093/ibd/izab271
Treatment of Fistulizing Perianal Crohn’s Disease by Autologous Microfat Enriched With Adipose-Derived Regenerative Cells
Karam Matlub Sørensen, MBChB, Charlotte Harken Jensen, PhD, Søren Paludan Sheikh, PhD, Niels Qvist, MD, Jens Ahm Sørensen, PhD
doi : 10.1093/ibd/izab276
Tofacitinib Inhibits Leukocyte Trafficking Across the Intestinal Endothelial Barrier in a Specific Cohort of Ulcerative Colitis Patients
Luca Massimino, PhD, Salvatore Spanò, MSc, Luigi Antonio Lamparelli, MSc, Davide Fuggetta, MSc, Laurent Peyrin-Biroulet, MD, PhD, Pierpaolo Sileri, MD, Silvio Danese, MD, PhD, Silvia D’Alessio, PhD, Federica Ungaro, PhD
doi : 10.1093/ibd/izab349
“The Tough Get Going�: Understanding the Role of Resilience and a Multidimensional Conceptualization of Mental Health Among Patients With Inflammatory Bowel Disease
Rachel C Lawton, PhD
doi : 10.1093/ibd/izab233
IBD in the Postpartum Period: Spotlight on Maternal Outcomes
Gabriella Bröms, MD, PhD
doi : 10.1093/ibd/izab170
Letter to the Editor: Re-Revisiting the Association Between Inflammatory Bowel Disease and Parkinson’s Disease
Inga Peter, PhD, Marla Dubinsky, MD, Si Xuan, MS, Naijun Chen, MS, Anthony Wang, PhD, MPH
doi : 10.1093/ibd/izac049
Response to the Letter to the Editor: “Re-Revisiting the Association Between Inflammatory Bowel Disease and Parkinson’s Disease�
Matthew D Coates, MD, PhD, Djibril M Ba, MPH, PhD, Guodong Liu, PhD, Shannon Dalessio, MA, Douglas L Leslie, PhD, Xuemei Huang, MD, PhD
doi : 10.1093/ibd/izac059
Inflammatory Bowel Disease Triggered by BNT162b2 mRNA Vaccination for SARS-CoV-2
Yosuke Shimodaira, MD, PhD, Kenta Watanabe, MD, So Takahashi, MD, Shigeto Koizumi, MD, PhD, Katsunori Iijima, MD, PhD
doi : 10.1093/ibd/izab297
COVID-19 as a Trigger for De Novo Crohn’s Disease
Antonio Tursi, MD, Rosanna Nenna, MD
doi : 10.1093/ibd/izab298
Granulomatous Pneumonia and Liver Lesions Associated With Crohn’s Disease
Xu Wang, MD, Jian Tang, PhD, Jian-Wei Zheng, MD, Wei-Feng Huang, PhD
doi : 10.1093/ibd/izab303
Pulmonary Infection Due to Reactivation of Latent Epstein-Barr Virus in a Patient With Crohn’s Disease Treated With Infliximab
Yajie Zhang, MD, PhD, Feng Tian, MD, PhD, Hui Li, MD, PhD
doi : 10.1093/ibd/izab304
A Rare Manifestation of IgG4-Related Disease and Concurrent Idiopathic Hypereosinophilic Syndrome as Extensive Gastrointestinal Lesions: A Case Report
Cong Dai, PhD, MD, Yu-hong Huang, MD
doi : 10.1093/ibd/izab307
Multifocal Pyoderma Gangrenosum at Presentation in a Patient With Acute Severe Ulcerative Colitis
Anuraag Jena, MD, DM, Anurag Sachan, MD, Anupam Kumar Singh, MD, DM, Vishal Sharma, MD, DM
doi : 10.1093/ibd/izab309
A Case of Behçet’s Disease With Hepatic Lesions Misdiagnosed as Crohn’s Disease
Baihui Wang, MM, Ruyuan LI, MM, Shuaiqing Zhang, MM, Qianqian Zhao, MM, Qing Wang, MM, Jie Yang, PhD, Aijun Zhang, MM
doi : 10.1093/ibd/izab322
The Importance of Physical Activity and Structured Exercise Distinction and Analysis-Response to “Physical Activity in Patients with Inflammatory Bowel Disease: A Narrative Review�
Jessica R Elia, DPT, CSCS, Kendall R Beck, MD
doi : 10.1093/ibd/izab323
The Importance of Physical Activity in Patients With Inflammatory Bowel Disease: A Narrative Review
Maitreyi Raman, MD, Raylene A Reimer, PhD, Subrata Ghosh, FMedSci, Jeff Vallance, PhD
doi : 10.1093/ibd/izab325
Network Clinical Collaboration to Improve Quality of Care of Patients With Inflammatory Bowel Disease in China
Ren Mao, MD, PhD, Siew Chien Ng, MD, PhD, Minhu Chen, MD, PhD
doi : 10.1093/ibd/izac091
Secondary Indicators for an Evaluation and Guidance System for Quality of Care in Inflammatory Bowel Disease Centers: A Critical Review of the Inflammatory Bowel Disease Quality of Care Center
Shen Jun, MD, PhD, Liang Jie, MD, PhD, Mao Ren, MD, PhD, Ran Zhihua, MD, PhD
doi : 10.1093/ibd/izac009
Challenging the Surge of Inflammatory Bowel Disease: The Role of the China Crohn’s and Colitis Foundation in the Healthcare Landscape of Inflammatory Bowel Disease
Lishan Peng, MSW, Shurong Hu, MD, PhD, Qiao Yu, MD, PhD, Yan Chen, MD, PhD
doi : 10.1093/ibd/izab344
Indications, Postoperative Management, and Long-term Prognosis of Crohn’s Disease After Ileocecal Resection: A Multicenter Study Comparing the East and West
Jeanine H C Arkenbosch, MSc, MD, Joyce W Y Mak, MD, PhD, Jacky C L Ho, MB, ChB, Evelien M J Beelen, MSc, MD, Nicole S Erler, PhD, Frank Hoentjen, MD, PhD, Alexander G L Bodelier, MD, PhD, Gerard Dijkstra, MD, PhD, Mariëlle Romberg-Camps, MD, PhD, Nanne K H de Boer, MD, PhD, Laurents P S Stassen, MD, PhD, Andrea E van der Meulen, MD, PhD, Rachel West, MD, PhD, Oddeke van Ruler, MD, PhD, Christien Janneke van der Woude, MD, PhD, Siew C Ng, MD, PhD, Annemarie C de Vries, MD, PhD
doi : 10.1093/ibd/izab316
Temporal Changes in the Treatment Paradigm and Long-term Prognosis of Patients With Crohn’s Disease: A Hospital-Based Cohort Study in China
Lingya Yao, MD, Haotian Chen, MD, Bule Shao, PhD, Jing Liu, PhD, Chaohui Wang, MD, Zhou Zhang, MD, Qian Cao, PhD
doi : 10.1093/ibd/izab327
Long-term Disease Behavior and Surgical Intervention Analysis in Hospitalized Patients With Crohn’s Disease in China: A Retrospective Cohort Study
Xiaoyin Bai, MD, Huimin Zhang, MD, Gechong Ruan, MD, Hong Lv, MD, Yue Li, MD, Ji Li, MD, Bei Tan, MD, Weiyang Zheng, MD, Meng Jin, MD, Hui Xu, MD, Hong Yang, MD, Jiaming Qian, MD
doi : 10.1093/ibd/izab295
Real-world Short-term Effectiveness of Ustekinumab in Crohn’s Disease: Results from a Multicenter, Prospective Study in China
Qian Cao, MD, Chunxiao Chen, MD, Xiang Gao, MD, Yan Chen, MD, Naizhong Hu, MD, Jie Liang, MD, PhD, Kaichun Wu, MD, PhD
doi : 10.1093/ibd/izac078
Current Status of Cytomegalovirus Colitis Among Patients With Inflammatory Bowel Disease in China: A Questionnaire-Based Multicenter Study
Hong Yang, MD, Jiaming Qian, MD
doi : 10.1093/ibd/izab358
Risks of Cardiovascular Events in Patients With Inflammatory Bowel Disease in China: A Retrospective Multicenter Cohort Study
Leilei Fang, MD, PhD, Han Gao, MSCE, Xiang Gao, MD, Wei Wu, MD, PhD, Yinglei Miao, MD, PhD, Hongjie Zhang, MD, PhD, Bayasi Guleng, MD, PhD, Hu Zhang, MD, PhD, Yufang Wang, MD, Mingsong Li, MD, Hong Yang, MD, Xiang Gao, MD, Jie Liang, MD, PhD, Qian Cao, MD, Jun Shen, MD, Zhihua Ran, MD, Kaichun Wu, MD, PhD, Jiaming Qian, MD, PhD, Minhu Chen, MD, PhD, Zhanju Liu, MD, PhD
doi : 10.1093/ibd/izab326
Prevalence of Malnutrition, Its Risk Factors, and the Use of Nutrition Support in Patients with Inflammatory Bowel Disease
Jing Liu, MD, Xiaolong Ge, MD, PhD, Chunhui Ouyang, MD, PhD, Dongxu Wang, MD, PhD, Xiaoqi Zhang, MD, PhD, Jie Liang, MD, PhD, Weiming Zhu, MD, PhD, Qian Cao, MD, PhD
doi : 10.1093/ibd/izab345
Longitudinal Bowel Behavior Assessed by Bowel Ultrasound to Predict Early Response to Anti-TNF Therapy in Patients With Crohn’s Disease: A Pilot Study
Yu-Jun Chen, MD, Bai-Li Chen, MD, Mei-Juan Liang, MS, Shu-Ling Chen, MD, Xue-Hua Li, MD, Yun Qiu, MD, Lan-Lan Pang, MB, Qing-Qing Xia, MS, Yao He, MD, Zhi-Rong Zeng, MD, Min-Hu Chen, MD, PhD, Ren Mao, MD, PhD, Xiao-Yan Xie, MD
doi : 10.1093/ibd/izab353
Treatment Decision-making in Chinese Inflammatory Bowel Disease Patients
Li Yang, MD, Xiaomei Song, MD, Yan Chen, MD, Yue Li, MD, Yubei Gu, MD, Xinying Wang, MD, Liangru Zhu, MD, Min Zhi, MD, Chunhui Ouyang, MD, Hong Guo, MD
doi : 10.1093/ibd/izab305
